Results show noninferiority to a full dose in preventing a recurrence of blood clots and an advantage when it comes to ...

Experts at City of Hope, a cancer research and treatment center, believe that AI tools will continue to improve precision ...

The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

Researchers report yet another positive finding for GLP-1s. The participants in this trial had lower BMIs than the participants in the many other trials that have shown the benefits of the GLP-1s.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

During last year’s enrollment period, millions of Medicare beneficiaries reviewed their coverage options and selected new ...

In a recent conversation with Jennifer McGuigan Babcock, senior vice president for Medicaid policy at the Association for ...

The Centers for Disease Control and Prevention’s Division of HIV Prevention are a critical source of funding and outreach for ...

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...

A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, ...

A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...